Business Context and Reporting Period
This Form 6-K filing by GSK plc covers the month of September 2024. The report serves as a notification to the market regarding the Company's total voting rights and capital structure as of August 31, 2024, in conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R.
Key Financial Metrics
The filing does not provide financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure data:
- Issued Share Capital: 4,314,232,277 Ordinary Shares of 31.25 pence each.
- Treasury Shares: 169,171,155 Ordinary Shares held in Treasury.
- Total Voting Rights: 4,145,061,122.
Material Changes
The filing text does not provide comparative data against a prior period to identify material changes in share capital or voting rights.
Guidance, Outlook, and Risks
The document contains no management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items. It is a statutory notification intended to assist shareholders in calculating their interest thresholds under FCA rules.
Investor Verification Checklist
- Verify the total number of voting rights (4,145,061,122) for compliance with FCA disclosure thresholds.
- Confirm the number of shares held in Treasury (169,171,155) to understand the float.
- Note that this filing does not contain operational or financial performance data; refer to Form 20-F or quarterly earnings releases for those metrics.